Common features/similarities to pathophysiological mechanisms in MS and comorbidity depression
Criteria | Depression/mood disorders | MS |
---|---|---|
HPA-axis dysfunction/stress/elevated cortisol release | [24, 28, 37, 38] | [26, 27, 30, 34–36] |
Imbalance of proinflammatory and antiinflammatory cytokines | [39–42, 44] | [12, 98, 154, 261] |
sNfL, an early biomarker for neuronal damage (“troponin of the neurologist”) | [45–47, 50–53] | [56–60, 62] |
sGFAP for diagnostics to detect “smoldering MS” and monitor the severity of the depression | [65, 68, 70] | [66, 69, 70] |
BBB disorders | [113–119] | [109, 110, 113] |
Microglial pathology | [20, 123, 128, 129] | [124–126] |
Gut microbiome disorders | [150, 151, 154, 156–158] | [145, 146] |